Update: Market Chatter: Lundbeck Said to Explore Potential Xeris Biopharma Acquisition

08:13 AM EDT, 09/30/2026 (MT Newswires) -- (Updates with Xeris Biopharma's response to a request for comment in the last paragraph.) H Lundbeck has been working with advisers to explore acquiring Xeris Biopharma Holdings (XERS), Bloomberg reported Tuesday, citing people familiar with the matter. There's no guarantee that Lundbeck's interest will culminate in a deal for the commercial-stage drugmaker, the report said, citing the people. Xeris declined to comment, while Lundbeck didn't immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)